Skip directly to content

Minimize RSR Award Detail

Research Spending & Results

Award Detail

Doing Business As Name:ThruPore Technologies
  • Franchessa M Sayler
  • (205) 657-0714
Award Date:09/09/2020
Estimated Total Award Amount: $ 256,000
Funds Obligated to Date: $ 256,000
  • FY 2020=$256,000
Start Date:09/01/2020
End Date:05/31/2021
Transaction Type:Grant
Awarding Agency Code:4900
Funding Agency Code:4900
CFDA Number:47.041
Primary Program Source:040100 NSF RESEARCH & RELATED ACTIVIT
Award Title or Description:SBIR Phase I: Antiviral Activity of Novel Nitrogen-Doped, Carbon Supported Catalysts Against Covid-19 Surrogates
Federal Award ID Number:2032653
DUNS ID:078479228
Parent DUNS ID:078479228
Program:SBIR Phase I
Program Officer:
  • Anna Brady-Estevez
  • (703) 292-7077

Awardee Location

Street:15 Reads Way, STE 107
City:New Castle
County:New Castle
Awardee Cong. District:00

Primary Place of Performance

Organization Name:ThruPore Technologies, Inc
Street:1500 1st Ave. N, Suite R134
Cong. District:07

Abstract at Time of Award

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project would be to slow the spread of viruses indoors, mitigating the need for social distancing. Microbes and viruses do not survive on specific surfaces. This project will explore if special nanoparticles can be used to kill viruses, such as that which causes COVID-19. This would help slow contagion and protect indoor spaces. This SBIR Phase I project proposes to determine if carbon supported nanoparticles can destructively deactivate SARS-CoV-2 under biologically realistic conditions. This project will explore novel nitrogen-doped carbon supports loaded with catalytic nanoparticles to destructively interact with SARS-CoV-2. Nitrogen in carbonaceous materials interacts with viruses and can increase performance in catalytic chemical reactions; however, to date this has not been leveraged at scale. In this project, three different types of nitrogen-doped carbon supports will be produced and compared against two state-of-practice carbon supports. Each support will have four different catalytic nanoparticles attached and then will be tested for efficacy. These catalysts will be compared on their ability to destroy coronavirus surrogates using an ASTM standardized test for evaluating medical mask efficiency. Once a suitable combination of catalyst support and catalytic nanoparticles is determined, the solution and process can be optimized. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

For specific questions or comments about this information including the NSF Project Outcomes Report, contact us.